Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Cystic fibrosis pulmonary guidelines: airway clearance therapies.
2009
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Conformational flexibility and molecular interactions of an archaeal homologue of the Shwachman-Bodian-Diamond syndrome protein
2009
Antibiotic Management of Lung Infections in Cystic Fibrosis. I. The Microbiome, Methicillin-Resistant Staphylococcus aureus , Gram-Negative Bacteria, and Multiple Infections
2014
Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death
1992
Developmental neurotoxicity of industrial chemicals
2006 Standout
Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients
2010
Eradication of early Pseudomonas aeruginosa infection
2005
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
In Vivo Delivery of RNAi with Lipid-Based Nanoparticles
2011
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination
2015 StandoutNobel
Cystic fibrosis
2016 Standout
Vaccination in Solid Organ Transplantation
2013
Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes
1995 StandoutNobel
The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of Exacerbations
2012
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
Gene delivery with synthetic (non viral) carriers
2001
Nitric oxide as a potential pathological mechanism in demyelination: Its differential effects on primary glial cellsin vitro
1994 StandoutNobel
Delivery materials for siRNA therapeutics
2013 Standout
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
2006
The biology and function of fibroblasts in cancer
2016 Standout
Clinical applications of C-reactive protein in pediatrics
1997 Standout
Effects of Gender and Age at Diagnosis on Disease Progression in Long-term Survivors of Cystic Fibrosis
2010
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
European Cystic Fibrosis Society Standards of Care: Quality Management in cystic fibrosis
2014
A new synthesis of galactose-poly(ethylene glycol)-polyethylenimine for gene delivery to hepatocytes
2002
Design and gene delivery activity of modified polyethylenimines
2001
Gene conversion causing human inherited disease: Evidence for involvement of non-B-DNA-forming sequences and recombination-promoting motifs in DNA breakage and repair
2009
Targeted gene delivery with trisaccharide-substituted chitosan oligomers in vitro and after lung administration in vivo
2006
Chitosan as a nonviral gene delivery system. Structure–property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo
2001
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs
2022
Aetiology of community-acquired pneumonia in children treated in hospital
1993
Non-viral vectors for gene-based therapy
2014 Standout
Acute kidney injury
2019 Standout
New pharmacological approaches for cystic fibrosis: Promises, progress, pitfalls
2014
Effect of Azithromycin on Pulmonary Function in Patients With Cystic Fibrosis Uninfected With <emph type="ital">Pseudomonas aeruginosa</emph><subtitle>A Randomized Controlled Trial</subtitle>
2010
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis
2003 Standout
A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis
2008
Human airway ion transport. Part one.
1994
Sequential antimicrobial therapy: treatment of severe lower respiratory tract infections in children
1999
Ceftazidime pharmacokinetics in preterm infants: Effects of renal function and gestational age*
1995
The prevalence of cystic fibrosis in the European Union
2008
Intravenous fate of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes
2003
Azithromycin fails to reduce increased expression of neutrophil-related cytokines in primary-cultured epithelial cells from cystic fibrosis mice
2009
Thermo- and pH-responsive polymers in drug delivery☆
2006 Standout
Ontogeny of Hepatic and Renal Systemic Clearance Pathways in Infants
2002
Gene delivery with low molecular weight linear polyethylenimines
2005
Modified poly(propylene imine) dendrimers as effective transfection agents for catalytic DNA enzymes (DNAzymes)
2006
Cystic fibrosis: a mucosal immunodeficiency syndrome
2012
Pharmacokinetics in the newborn
2003
Cystic Fibrosis Pulmonary Guidelines
2013
Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease
2001
Biomarkers of Drug-Induced Kidney Toxicity
2018
Airway Mucus Function and Dysfunction
2010 Standout
Cystic fibrosis microbiology: Advances in antimicrobial therapy
2015
Different behavior of branched and linear polyethylenimine for gene deliveryin vitro andin vivo
2001
Effects of antihypertensive drugs on blood pressure and proteinuria in childhood
2007
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)
2012 Standout
Reactive Astrocytes: Production, Function, and Therapeutic Potential
2017 Standout
Quantification of β-galactosidase activity after non-viral transfection in vivo
2003
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Application of Novel Solid Lipid Nanoparticle (SLN)-Gene Vector Formulations Based on a Dimeric HIV-1 TAT-Peptide in Vitro and in Vivo
2004
Infections in Patients with Cystic Fibrosis
2014
Knocking down barriers: advances in siRNA delivery
2009 Standout
Gold Nanorods: From Synthesis and Properties to Biological and Biomedical Applications
2009 Standout
Macrolides Promote CCL2-Mediated Macrophage Recruitment and Clearance of Nasopharyngeal Pneumococcal Colonization in Mice
2015 StandoutNobel
Polyethylenimine-based non-viral gene delivery systems
2005
Ontogeny of Hepatic and Renal Systemic Clearance Pathways in Infants
2002
Gene Transfer by Means of Lipo- and Polyplexes: Role of Clathrin and Caveolae-Mediated Endocytosis
2006
Incorporating pharmacokinetic differences between children and adults in assessing children's risks to environmental toxicants
2004
The dawning era of polymer therapeutics
2003 Standout
Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
2012
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
Ionizable Amino‐Polyesters Synthesized via Ring Opening Polymerization of Tertiary Amino‐Alcohols for Tissue Selective mRNA Delivery
2018
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta
2023 StandoutNobel
Aquaporins in complex tissues. II. Subcellular distribution in respiratory and glandular tissues of rat
1997 StandoutNobel
Inflammation and its genesis in cystic fibrosis
2015
Integrity of the P-site is probed during maturation of the 60S ribosomal subunit
2012 StandoutNobel
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
Nonviral Vectors for Gene Delivery
2008 Standout
Chitosan—A versatile semi-synthetic polymer in biomedical applications
2011 Standout
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 StandoutNobel
ListeriaPathogenesis and Molecular Virulence Determinants
2001 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
An Evolutionary View of the Mechanism for Immune and Genome Diversity
2012 StandoutNobel
The lack of a functional p21 WAF1/CIP1 gene ameliorates progression to chronic renal failure
1999
Exosomes with Immune Modulatory Features Are Present in Human Breast Milk
2007 Standout
Aquaporins in complex tissues. I. Developmental patterns in respiratory and glandular tissues of rat
1997 StandoutNobel
Pathophysiology of the Aquaporin Water Channels
1996 StandoutNobel
Cellular uptake of nanoparticles: journey inside the cell
2017 Standout
Evolutionary Comparison of the Mechanism of DNA Cleavage with Respect to Immune Diversity and Genomic Instability
2012 StandoutNobel
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Contribution of bone marrow-derived fibrocytes to liver fibrosis.
2015
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Pathogenesis and pathophysiology of bacterial meningitis
1993
Relationship of gentamicin serum concentrations to gestational age in preterm and term neonates
1980
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population
2010
Works of B.M. Assael being referenced
Reference percentiles for FEV1 and BMI in European children and adults with cystic fibrosis
2012
Time Trends in Birth Incidence of Cystic Fibrosis in Two European Areas: Data from Newborn Screening Programs
2007
Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: A comparative efficacy trial
2012
Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry
2006
Acute pyelonephritis as a cause of hyponatremia/hyperkalemia in young infants with urinary tract malformations
1995
Counterimmunoelectrophoresis and latex particle agglutination in the etiologic diagnosis of presumed bacterial pneumonia in pediatric patients
1988
Early antibiotic treatment of pseudomonas aeruginosa colonisation in cystic fibrosis: a critical review of the literature
2004
Adequate clinical control of congenital nephrotic syndrome by enalapril
1998
Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs
1999
PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients
2010
Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells
2006
An international/multicentre report on patients with cystic fibrosis (CF) over the age of 40 years
2008
Interleukin 6 activity in infants and children with bacterial meningitis
1991
Defective CFTR Expression and Function Are Detectable in Blood Monocytes: Development of a New Blood Test for Cystic Fibrosis
2011
Impact of the A (H1N1) pandemic influenza (season 2009–2010) on patients with cystic fibrosis
2011
Cystic fibrosis carriers have higher neonatal immunoreactive trypsinogen values than non‐carriers
2005
Immunity to poliomyelitis, diphtheria and tetanus in pediatric patients before and after renal or liver transplantation
1999
Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs
2000
Identification of novel mutations in patients with Shwachman-Diamond syndrome
2005
IL-8 and pH Values in Exhaled Condensate after Antibiotics in Cystic Fibrosis Children
2007
Duration of immunity to diphtheria and tetanus in young kidney transplant patients
1999
MPB-07 Reduces the Inflammatory Response to Pseudomonas aeruginosa in Cystic Fibrosis Bronchial Cells
2006
Kinetics and efficacy of theophylline in the treatment of apnea in the premature newborn
1978
Azithromycin Selectively Reduces Tumor Necrosis Factor Alpha Levels in Cystic Fibrosis Airway Epithelial Cells
2007
Subtotal but not unilateral nephrectomy induces hyperplasia and protooncogene expression
1995
Renal Function in Cystic Fibrosis
1986
Follow-up study of enzymuria and ? 2 microglobulinuria during cis-platinum treatment
1985
Comparison of the concentrations of ceftazidime in the serum of newborn infants after intravenous and intramuscular administration
1983
Disposition of pulse dose methylprednisolone in adult and paediatric patients with the nephrotic syndrome
1982
Chest physiotherapy with positive airway pressure: a pilot study of short-term effects on sputum clearance in patients with cystic fibrosis and severe airway obstruction.
2006
Pharmacokinetics and drug distribution during postnatal development
1982
Gentamicin dosage in preterm and term neonates.
1977
Theophylline Metabolism during the First Month of Life and Development
1981